CRISPR Therapeutics
CRSP
CRSP
410 hedge funds and large institutions have $7.23B invested in CRISPR Therapeutics in 2020 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 132 increasing their positions, 88 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
410
Holders Change
+101
Holders Change %
+32.69%
% of All Funds
7.27%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
138
Increased
132
Reduced
88
Closed
35
Calls
$294M
Puts
$278M
Net Calls
+$16.1M
Net Calls Change
+$17.8M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
$1.59B |
| 2 |
Morgan Stanley
New York
|
$112M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$45.5M |
| 4 |
Jane Street
New York
|
$28.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
$46.8M |
